Federal Circuit Opinion on Heart Medication May Raise Generics' Blood Pressure
Client Alert | less than 1 min read | 10.08.20
Insights
Client Alert | 3 min read | 07.21.25
Bypass Applications in U.S. Patent Practice: A Strategic Alternative to National Stage Entry
Applicants entering the U.S. national phase of an international (PCT) application have two options: enter the national stage under 35 U.S.C. §371 or file a “bypass” national application under 35 U.S.C. § 111(a). A bypass application allows applicants to file a new U.S. application that claims priority to the PCT application, treating the PCT application as a U.S. parent and bypassing the traditional national phase entry. Depending on the applicant’s goals and strategy, bypass applications can be filed as a continuation, divisional, or continuation-in-part (CIP).
Client Alert | 1 min read | 07.21.25
Client Alert | 4 min read | 07.21.25
Not So Surprising: The Fifth Circuit Finds No Private Right of Action in the No Surprises Act
Client Alert | 3 min read | 07.18.25